190 results
Page 9 of 10
PRE 14A
vtc40v3
14 Mar 13
Preliminary proxy
12:00am
424B5
oobbsfx4six8djo
31 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
nsppnd06 m8ewcuvor42
31 Jan 13
NewLink Genetics Corporation Announces Proposed Public Offering of Common Stock
12:00am
424B5
sr9dr8xixuzk
29 Jan 13
Prospectus supplement for primary offering
12:00am
8-K
EX-10.1
w4gfxnkrcli1qhrd
18 Jan 13
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
svr03cr9ujpzeapn
3 Oct 12
NewLink Genetics Launches Adaptive Design Phase 2B/3 Clinical Trial of tergenpumatucel-L Immunotherapy in Patients with Non-Small Cell Lung Cancer
12:00am
8-K
EX-99.1
runutruizr48 x6aye2
21 Sep 12
Other Events
12:00am
DEF 14A
51e9chm6kvk2iaj1jkdm
21 Sep 12
Definitive proxy
12:00am
8-K
klw3vs jjlp5d
27 Jun 12
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
iuba40f4
5 Jun 12
Other Events
12:00am
10-K
bcw7fsppiu22i
30 Mar 12
Annual report
12:00am